Bone Biologics Corporation (BBLG) financial statements and ratios from SEC XBRL: revenue $1.07B (TTM), net margin -0.2%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $1.07B |
| Net Margin | -0.2% |
| Price / Book | 0.42 |
| Sector P/E (Healthcare) | 21.6 |
BBLG overview · BBLG earnings · BBLG KPIs · BBLG investor relations · BBLG ownership · BBLG peers · BBLG filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.